Vaxcyte, Inc.
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
PCVX$67.53+5.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Incorporated by Reference | |||||
|---|---|---|---|---|---|
| ExhibitNumber | Description | ScheduleForm | FileNumber | Exhibit | FilingDate |
| 3.1 | Second Amended and Restated Certificate of Incorporation of Vaxcyte, Inc. | 10-K | 001-39323 | 3.1 | February 24, 2026 |
| 3.2 | Amended and Restated Bylaws of Vaxcyte, Inc., as amended. | 10-Q | 001-39323 | 3.2 | November 6, 2023 |
| 4.1 | Form of Common Stock Certificate of the Registrant. | S-1/A | 333-238630 | 4.1 | June 8, 2020 |
| 4.2 | Form of Pre-Funded Warrant. | 8-K | 001-39323 | 4.1 | January 13, 2022 |
| 4.3 | Form of Pre-Funded Warrant. | 8-K | 001-39323 | 4.1 | October 27, 2022 |
| 4.4 | Form of Pre-Funded Warrant. | 8-K | 001-39323 | 4.1 | April 20, 2023 |
| 4.5 | Form of Pre-Funded Warrant. | 8-K | 001-39323 | 4.1 | January 31, 2024 |
| 4.6 | Form of Pre-Funded Warrant. | 8-K | 001-39323 | 4.1 | September 6, 2024 |
| 10.1# | Second Amendment to Executive Change in Control and Severance Agreement entered into by and between the Registrant and Mikhail Eydelman. | X | |||
| 31.1 | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | |||
| 31.2 | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | |||
| 32.1† | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | |||
| 101.INS | Inline XBRL Instance Document: the instance document does not appear in the interactive Data File because its XBRL tags are embedded within the Inline XBRL document | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | ||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | ||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||
| 104 | Inline XBRL for the cover page of the Quarterly Report on Form 10-Q included in the Exhibit 101 Inline XBRL Document Set. | ||||
XFiled herewith.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.